BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32778364)

  • 1. [Adherence to biological therapies in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. (Study ADhER-1)].
    Núñez-Rodríguez J; González-Pérez Y; Nebot-Villacampa MJ; Zafra-Morales R; Obaldia-Alaña MC; Caso-González A
    Semergen; 2021 Mar; 47(2):81-90. PubMed ID: 32778364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to biological therapies in patients with chronic inflammatory arthropathies.
    Martínez-López de Castro N; Álvarez-Payero M; Samartín-Ucha M; Martín-Vila A; Piñeiro-Corrales G; Pego Reigosa JM; ; Rodríguez-Rodríguez M; Melero-González RB; Maceiras-Pan FJ
    Farm Hosp; 2019 Jul; 43(4):134-139. PubMed ID: 31276446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
    Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J
    RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease (AdhER-2 study)].
    Caso-González A; Núñez-Rodríguez J; González-Pérez Y; Leralta-González C; Sanz-Alonso V; Obaldia-Alaña C
    An Sist Sanit Navar; 2022 Aug; 45(2):. PubMed ID: 35972301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Treatment Patterns in Patients with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up.
    Cañete JD; Naranjo A; Calvo J; Ordás C; Aragón B; Nocea G; Roset M; Fernández-Nebro A
    Reumatol Clin (Engl Ed); 2020; 16(6):447-454. PubMed ID: 30704919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Walsh JA; Pei S; Alexander S; Braaten T; Walker JH; Clewell J; Douglas KM; Penmetsa GK; Ye X; Breviu B; Cannon GW; Kunkel GA; Sauer BC
    Semin Arthritis Rheum; 2024 Jun; 66():152436. PubMed ID: 38714073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance.
    Walsh JA; Pei S; Burningham Z; Penmetsa G; Cannon GW; Clegg DO; Sauer BC
    J Rheumatol; 2018 Mar; 45(3):430-436. PubMed ID: 29142040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
    Ogdie A; de Vlam K; McInnes IB; Mease PJ; Baer P; Lukic T; Gruben D; Kwok K; Wang C; Hsu MA; Maniccia A
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32396519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to treatment in patients with ankylosing spondylitis.
    Arturi P; Schneeberger EE; Sommerfleck F; Buschiazzo E; Ledesma C; Maldonado Cocco JA; Citera G
    Clin Rheumatol; 2013 Jul; 32(7):1007-15. PubMed ID: 23515597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.
    Fantò M; Peragallo MS; Pietrosanti M; Di Rosa R; Picchianti Diamanti A; Salemi S; D'Amelio R
    Intern Emerg Med; 2016 Feb; 11(1):31-40. PubMed ID: 26099279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiographic changes in the temporomandibular joint of patients with rheumatoid arthritis, psoriatic, arthritis, and ankylosing spondylitis.
    Wenneberg B; Könönen M; Kallenberg A
    J Craniomandib Disord; 1990; 4(1):35-9. PubMed ID: 2098385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniomandibular disorders in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. A clinical study.
    Könönen M; Wenneberg B; Kallenberg A
    Acta Odontol Scand; 1992 Oct; 50(5):281-7. PubMed ID: 1441932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study.
    Martínez-López-de-Castro N; Álvarez-Payero M; Samartín-Ucha M; Martínez-Reglero C; Martín-Vila A; Rodríguez-Rodríguez M; Piñeiro-Corrales G; Maceiras-Pan JF; Melero-González RB; Pego-Reigosa JM
    Clin Exp Rheumatol; 2021; 39(4):736-745. PubMed ID: 32896255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
    Wolfe RM; Ang DC
    Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence and treatment-free interval in patients being prescribed biological drugs in rheumatology practices in Germany.
    Kostev K; Jacob L
    Eur J Clin Pharmacol; 2019 May; 75(5):717-722. PubMed ID: 30666350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment of psoriatic arthritis and axial spondyloarthritis with traditional biologic and non-biologic DMARDs.
    Soriano ER; Acosta-Felquer ML; Luong P; Caplan L
    Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):793-806. PubMed ID: 25488785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis.
    Torre Alonso JC; Díaz Del Campo Fontecha P; Almodóvar R; Cañete JD; Montilla Morales C; Moreno M; Plasencia-Rodríguez C; Ramírez García J; Queiro R
    Reumatol Clin (Engl Ed); 2018; 14(5):254-268. PubMed ID: 29111261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.